Cargando…
Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions
The anti-cancer role of miR-206 in hepatocellular carcinoma (HCC) cells has been reported, but its mechanism of action remains poorly understood. This research aimed to investigate the anti-HCC mechanism of miR-206. We analyzed 25 pairs of HCC and adjacent tissue specimens from HCC patients. Two pat...
Autores principales: | He, Qiang, Du, Haiyan, Li, Yundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059747/ https://www.ncbi.nlm.nih.gov/pubmed/35518051 http://dx.doi.org/10.1039/c8ra09229j |
Ejemplares similares
-
Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions
por: Fisher, Laura
Publicado: (2021) -
MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis
por: Zhan, Fang-Biao, et al.
Publicado: (2019) -
Retracted: miR-206 Inhibits Laryngeal Carcinoma Cell Multiplication, Migration, and Invasion
por: Healthcare Engineering, Journal of
Publicado: (2023) -
miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
por: Pang, Chi, et al.
Publicado: (2017) -
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
por: Chen, Qing-yong, et al.
Publicado: (2016)